Previous Article | Next Article 
Journal of Virology, June 2005, p. 7466-7477, Vol. 79, No. 12
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.12.7466-7477.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection
Erin Mehlhop,3,
Kevin Whitby,1,
Theodore Oliphant,2
Anantha Marri,1
Michael Engle,1 and
Michael S. Diamond1,2,3*
Departments of Medicine,1
Molecular Microbiology,2
Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri 631103
Received 15 December 2004/
Accepted 15 February 2005
Infection with West Nile virus (WNV) causes a severe infection of the central nervous system (CNS) with higher levels of morbidity and mortality in the elderly and the immunocompromised. Experiments with mice have begun to define how the innate and adaptive immune responses function to limit infection. Here, we demonstrate that the complement system, a major component of innate immunity, controls WNV infection in vitro primarily in an antibody-dependent manner by neutralizing virus particles in solution and lysing WNV-infected cells. More decisively, mice that genetically lack the third component of complement or complement receptor 1 (CR1) and CR2 developed increased CNS virus burdens and were vulnerable to lethal infection at a low dose of WNV. Both C3-deficient and CR1- and CR2-deficient mice also had significant deficits in their humoral responses after infection with markedly reduced levels of specific anti-WNV immunoglobulin M (IgM) and IgG. Overall, these results suggest that complement controls WNV infection, in part through its ability to induce a protective antibody response.
* Corresponding author. Mailing address: Departments of Medicine, Molecular Microbiology, and Pathology & Immunology, Washington University School of Medicine, 660 South Euclid Ave., Box 8051, St. Louis, MO 63110. Phone: (314) 362-2842. Fax: (314) 362-9230. E-mail:
diamond{at}borcim.wustl.edu.
These authors contributed equally to the work.
Journal of Virology, June 2005, p. 7466-7477, Vol. 79, No. 12
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.12.7466-7477.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Benhnia, M. R.-E.-I., McCausland, M. M., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L., Tahara, T., Kubo, R. T., Kato, S., Crotty, S.
(2009). Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5. J. Virol.
83: 12355-12367
[Abstract]
[Full Text]
-
Schweitzer, B. K., Chapman, N. M., Iwen, P. C.
(2009). Overview of the Flaviviridae With an Emphasis on the Japanese Encephalitis Group Viruses. Lab Med
40: 493-499
[Abstract]
[Full Text]
-
Krishna, V. D., Rangappa, M., Satchidanandam, V.
(2009). Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells. J. Virol.
83: 4766-4777
[Abstract]
[Full Text]
-
Benhnia, M. R.-E.-I., McCausland, M. M., Moyron, J., Laudenslager, J., Granger, S., Rickert, S., Koriazova, L., Kubo, R., Kato, S., Crotty, S.
(2009). Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement. J. Virol.
83: 1201-1215
[Abstract]
[Full Text]
-
Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R. III, Castro, E., Akondy, R., Rinfret, A., Yassine-Diab, B., Said, E. A., Chouikh, Y., Cameron, M. J., Clum, R., Kelvin, D., Somogyi, R., Greller, L. D., Balderas, R. S., Wilkinson, P., Pantaleo, G., Tartaglia, J., Haddad, E. K., Sekaly, R.-P.
(2008). Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. JEM
205: 3119-3131
[Abstract]
[Full Text]
-
Purtha, W. E., Chachu, K. A., Virgin, H. W. IV, Diamond, M. S.
(2008). Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling. J. Virol.
82: 10964-10974
[Abstract]
[Full Text]
-
Girgis, N. M., DeHaven, B. C., Fan, X., Viner, K. M., Shamim, M., Isaacs, S. N.
(2008). Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack. J. Virol.
82: 4205-4214
[Abstract]
[Full Text]
-
Zaiss, A. K., Cotter, M. J., White, L. R., Clark, S. A., Wong, N. C. W., Holers, V. M., Bartlett, J. S., Muruve, D. A.
(2008). Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors. J. Virol.
82: 2727-2740
[Abstract]
[Full Text]
-
Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C., Diamond, M. S.
(2007). Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus. J. Virol.
81: 11828-11839
[Abstract]
[Full Text]
-
Sitati, E., McCandless, E. E., Klein, R. S., Diamond, M. S.
(2007). CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis. J. Virol.
81: 9801-9811
[Abstract]
[Full Text]
-
Fang, C., Miwa, T., Shen, H., Song, W.-C.
(2007). Complement-Dependent Enhancement of CD8+ T Cell Immunity to Lymphocytic Choriomeningitis Virus Infection in Decay-Accelerating Factor-Deficient Mice. J. Immunol.
179: 3178-3186
[Abstract]
[Full Text]
-
Morrison, T. E., Fraser, R. J., Smith, P. N., Mahalingam, S., Heise, M. T.
(2007). Complement Contributes to Inflammatory Tissue Destruction in a Mouse Model of Ross River Virus-Induced Disease. J. Virol.
81: 5132-5143
[Abstract]
[Full Text]
-
Sitati, E. M., Diamond, M. S.
(2006). CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System. J. Virol.
80: 12060-12069
[Abstract]
[Full Text]
-
Oliphant, T., Nybakken, G. E., Engle, M., Xu, Q., Nelson, C. A., Sukupolvi-Petty, S., Marri, A., Lachmi, B.-E., Olshevsky, U., Fremont, D. H., Pierson, T. C., Diamond, M. S.
(2006). Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein. J. Virol.
80: 12149-12159
[Abstract]
[Full Text]
-
Chung, K. M., Liszewski, M. K., Nybakken, G., Davis, A. E., Townsend, R. R., Fremont, D. H., Atkinson, J. P., Diamond, M. S.
(2006). From the Cover: West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. USA
103: 19111-19116
[Abstract]
[Full Text]
-
Samuel, M. A., Diamond, M. S.
(2006). Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion. J. Virol.
80: 9349-9360
[Full Text]
-
Wang, T., Gao, Y., Scully, E., Davis, C. T., Anderson, J. F., Welte, T., Ledizet, M., Koski, R., Madri, J. A., Barrett, A., Yin, Z., Craft, J., Fikrig, E.
(2006). {gamma}{delta} T Cells Facilitate Adaptive Immunity against West Nile Virus Infection in Mice. J. Immunol.
177: 1825-1832
[Abstract]
[Full Text]
-
Throsby, M., Geuijen, C., Goudsmit, J., Bakker, A. Q., Korimbocus, J., Kramer, R. A., Clijsters-van der Horst, M., de Jong, M., Jongeneelen, M., Thijsse, S., Smit, R., Visser, T. J., Bijl, N., Marissen, W. E., Loeb, M., Kelvin, D. J., Preiser, W., ter Meulen, J., de Kruif, J.
(2006). Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile Virus. J. Virol.
80: 6982-6992
[Abstract]
[Full Text]
-
Mehlhop, E., Diamond, M. S.
(2006). Protective immune responses against West Nile virus are primed by distinct complement activation pathways. JEM
203: 1371-1381
[Abstract]
[Full Text]
-
Chung, K. M., Nybakken, G. E., Thompson, B. S., Engle, M. J., Marri, A., Fremont, D. H., Diamond, M. S.
(2006). Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc {gamma} Receptor-Dependent and -Independent Mechanisms. J. Virol.
80: 1340-1351
[Abstract]
[Full Text]